awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41483502-35C57329-0AEC-403D-AA07-90160DBA0AA3
Q41483502-35C57329-0AEC-403D-AA07-90160DBA0AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41483502-35C57329-0AEC-403D-AA07-90160DBA0AA3
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients.
P2860
Q41483502-35C57329-0AEC-403D-AA07-90160DBA0AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41483502-35C57329-0AEC-403D-AA07-90160DBA0AA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
789da9ad6bfdb771ea8c3304ad83ad3ad3a0ca60
P2860
A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients